Pre - PA Allowance. Prior-Approval Requirements LEVORPHANOL TARTRATE. None

Similar documents
HYSINGLA ER (hydrocodone bitartrate) Prior authorization is not required if prescribed by an oncologist.

MORPHINE IR DRUG CLASS Morphine IR, Dilaudid IR (hydromorphone), Opana IR (oxymorphone)

Duragesic Patch (fentanyl patch) Prior authorization is not required if prescribed by an oncologist

90 dosage units per 90 days OR. Extended-release Formulations Ultram ER 90 dosage units per 90 days OR

Levorphanol. Levorphanol Tartrate. Description

Levorphanol. Levorphanol Tartrate. Description

Hysingla ER. Hysingla ER (hydrocodone bitartrate) Description

Embeda. Embeda (morphine sulfate and naltrexone hydrochloride) Description

Nucynta IR. Nucynta IR (tapentadol immediate-release) Description

Duragesic patch. Duragesic patch (fentanyl patch) Description

Butrans (buprenorphine patch) Description. Section: Prescription Drugs Effective Date: October 1, 2017

Belbuca (buprenorphine buccal film) Belbuca (buprenorphine buccal film) Description

Duragesic patch. Duragesic patch (fentanyl patch) Description

BELBUCA (buprenorphine buccal film)

Belbuca (buprenorphine buccal film) Description. Section: Prescription Drugs Effective Date: October 1, 2016

Xartemis XR (oxycodone / acetaminophen extended release)

OXYCODONE IR (oxycodone)

Demerol (meperidine oral tablet, oral solution), Meperitab (oral tablet)

Duragesic patch. Duragesic patch (fentanyl patch) Description. Section: Prescription Drugs Effective Date: January 1, 2019

Targiniq ER (oxycodone/naloxone extended-release), Troxyca ER (oxycodone /naltrexone extended-release)

Morphine IR Hydromorphone IR Oxymorphone IR. Morphine IR, Dilaudid IR (hydromorphone), Opana IR (oxymorphone),

Oxycodone. Oxycodone IR, Oxycodone ER, OxyContin, Xtampza ER. Description

Oxycodone. Oxycodone IR, Oxycodone ER, OxyContin, Xtampza ER. Description

RATIONALE FOR INCLUSION IN PA PROGRAM

RATIONALE FOR INCLUSION IN PA PROGRAM

RATIONALE FOR INCLUSION IN PA PROGRAM

Methadone. Description

Methadone. Description

Morphine Sulfate Hydromorphone Oxymorphone

Morphine Sulfate Hydromorphone Oxymorphone

Extended Release Opioid Drugs

Extended Release Opioid Drugs

Extended Release Opioid Drugs

Background Apadaz (benzhydrocodone-acetaminophen), codeine-acetaminophen, dihydrocodeine-caffeineacetaminophen,

PHYSICIAN REFERENCE ANTIDEPRESSANT DOSING GUIDELINES

Medications and Children Disorders

Major Depressive Disorder

Antidepressant Medication Strategies We ve Come a Long Way or Have We? Who Writes Prescriptions for Psychotropic Medications. Biological Psychiatry

USF Health Psychiatry Clinic. New Patient Questionnaire Adult

BRIEF ANTIDEPRESSANT OVERVIEW. Casey Gallimore, Pharm.D., M.S.

Appendix: Psychotropic Medication Reference Tables

20/0.8mg, 30/1.2mg, Films 90 MME/day Belbuca (buprenorphine) 75mcg, 150mcg, 300mcg, 450mcg 60 units per 90 days

Medications Guide: Public Speaking And Social Anxiety

U T I L I Z A T I O N E D I T S

Dealing with a Mental Health Crisis

Study Guidelines for Quiz #1

PATIENT FACE SHEET PATIENT NAME: PATIENT DOB: PATIENT PHONE #: INSURANCE: MEMBER ID: GROUP NUMBER: PATIENT ADDRESS

Treatment of Major Depressive Disorder

Pharmacotherapy of Anxiety Disorders (GAD, Panic, & SAD) Declaration of Interests

Objectives: Lifetime prevalence. Neurotransmitters of interest

POSITIVE YOUTH CONCEPTS Child and Adolescent Therapy 24 Front Street, Suite 302 Exeter, NH

Prepared by: Elizabeth Vicens-Fernandez, LMHC, Ph.D.

IMPORTANT NOTICE. Changes to dispensing of some Behavioral Health Medications for DC Healthcare Alliance members

Drug Effectiveness Review Project (DERP) Summary Report on Second-Generation Antidepressants and Antidepressants Literature Scan

MAJOR DEPRESSION CLINICAL PRACTICE GUIDELINE

Commissioner for the Department for Medicaid Services Selections for Preferred Products

Bridges to Excellence Depression Care Recognition Program Guide

Psychotropic Medications Archana Jhawar, PharmD, BCPP Clinical Faculty of UIC Pharmacy Practice Clinical Psychiatric Pharmacist Jesse Brown VA

Psychiatric Evaluation Intake Form

Review of Psychotrophic Medications. (An approved North Carolina Division of Health Services Regulation Continuing Education Course)

Psychiatric Evaluation Intake Form

Overview and Update on Current Psychopharmacological Medications, Including New Medications in Clinical Trials

PSYCHIATRIC HISTORY 6. Are you currently seeing a therapist? (Name & contact phone#)

Guide to Psychiatric Medications for Children and Adolescents

Depression. There are several forms of depression (depressive disorders). Major depressive disorder and dysthymic disorder are the most common.

Happy Daisy Ltd. New Client intake Form. What are the issues for which you are seeking care?

CENPATICO INTEGRATED CARE BEHAVIORAL HEALTH DRUG LIST BY DRUG NAME. Use Brand Only

mood treatment center.com brain art from Hope Street Mental Health Greeting cards (hopestreetcards.com.au)

9/17/2015 DIAGNOSTIC PUZZLES LEARNING OBJECTIVES MENTAL ILLNESS MEDICAL COMORBIDITIES

Clinical Policy: Vilazodone (Viibryd) Reference Number: CP.PMN.145 Effective Date: Last Review Date: Line of Business: HIM, Medicaid

Mental Health Medications. National Institute of Mental Health. U.S. Department of HealtH and HUman ServiceS National Institutes of Health

Briefly state the reason for this evaluation: Patient s Name: Sex: Male/Female (circle one) Date of Birth: Age: Patient s Social Security #

Depression Pharmacology. PHPP 517 (IT-III) Fall 2011

HARVARD PILGRIM HEALTH CARE RECOMMENDED MEDICATION REQUEST GUIDELINES

See Important Reminder at the end of this policy for important regulatory and legal information.

Available Strengths Limits. 10 mg tablet -- $ mg tablet -- $ mg tablet -- $ mg tablet -- $72.41 Avoid use in members over

Linda Sobeski Farho, PharmD, BCPS Assistant Professor, Pharmacy Practice UNMC College of Pharmacy Critical Issues in Geriatrics June 24, 2010

Monoamine oxidase inhibitors (MAOIs) have wellestablished

MO Medicaid Foster Care Drugs FY10-FY14

Before you try another medication, try asking your DNA

Use Brand Only. Preferred Drug Status PRIOR AUTHORIZATION REQUIRED

Trintellix dose it cause weight gain

CENPATICO INTEGRATED CARE BEHAVIORAL HEALTH DRUG LIST BY DRUG CLASS

Objectives. Diagnostic Criteria DSM 5. Before we begin I should tell you that. General Diagnostics for Anxiety Disorders 08/02/2014

Antidepressant Agents Step Therapy and Quantity Limit Program Summary

Psychobiology Handout

Clinical Policy: Levomilnacipran (Fetzima) Reference Number: HIM.PA.125 Effective Date: Last Review Date: 11.18

AHCCCS BEHAVIORAL HEALTH DRUG LIST EFFECTIVE OCTOBER 1, 2016

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

NorthSTAR. Pharmacy Manual

Iowa Medicaid Mental Health Advisory Group Meeting February 13, Tentative Agenda

Steps for Initiating Electroconvulsive Therapy Treatment

Richard Heidenfelder M.D. Child, Adolescent and Adult Psychiatry 447 9th Ave San Diego, CA

Tranylcypromine. Why is this medication prescribed? How should this medicine be used? 1 of 5 7/6/ :31 PM. (tran il sip' roe meen) Warning

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

Patients considering TMS Therapy

PSYCHIATRY INTAKE FORM

Psychiatric Illness. In the medical arena psychiatry is a fairly recent field A challenging field Numerous diagnosis

Psychopharmacological Management of Depressive and Anxiety Disorders

Depression: Optimizing Outcomes for the Individual Patient

Transcription:

Pre - PA Allowance None Prior-Approval Requirements Prior authorization is not required if prescribed by an oncologist and/or the member has paid pharmacy claims for an oncology medication(s) in the past 6 months Age 18 years of age or older Diagnosis Patient must have the following: 1. Moderate to severe pain AND ALL of the following: a. NO dual therapy with other immediate release opioid analgesic(s) b. Alternative treatment options have been ineffective, not tolerated or inadequate for controlling the pain i. These include non-opioid analgesic(s), or opioid combination products c. Prescriber agrees to assess the benefits of pain control (i.e. Care Plan signs of abuse, severity of pain) after 3 months of therapy d. Prescriber agrees to assess patient for serotonin syndrome e. NO dual therapy with opioid addiction treatment or methadone f. NO dual therapy with an anti-anxiety benzodiazepine(s) i. Alprazolam (Xanax) ii. Clonazepam (Klonopin) iii. Diazepam (Valium) iv. Lorazepam (Ativan) v. Oxazepam (Serax) vi. Chlordiazepoxide (Librium) vii. Clorazepate dipotassium (Tranxene) AND ONE of the following: 1. Opioid naïve patient and opioid non-tolerant patient initiation therapy MUST start at 2mg every 6 to 8 hours as needed AND for no less than 7 days before changing to a higher dose OR

Prior - Approval Limits 1. Opioid tolerant patient patients are considered opioid tolerant if they have been receiving, for one week or longer, at least one of the following: a. 60 mg oral morphine per day b. 25 mcg transdermal fentanyl per hour c. 30 mg oral oxycodone per day d. 8 mg oral hydromorphone per day e. 25 mg oral oxymorphone per day f. Or an equianalgesic dose of another opioid Opioid naïve / opioid non-tolerant Quantity 2 mg 360 tablets per 90 days Opioid tolerant Quantity 2 mg 540 tablets per 90 days Prior Approval Renewal Requirements Age 18 years of age or older Diagnosis Patient must have the following: 1. Moderate to severe pain AND ALL of the following: a. NO dual therapy with other immediate release opioid analgesic(s) b. Prescriber agrees to assess the benefits of pain control (i.e. Care Plan signs of abuse, severity of pain) after 3 months of therapy c. Prescriber agrees to assess patient for serotonin syndrome d. NO dual therapy with opioid addiction treatment or methadone e. NO dual therapy with an anti-anxiety benzodiazepine(s) i. Alprazolam (Xanax) ii. Clonazepam (Klonopin)

iii. Diazepam (Valium) iv. Lorazepam (Ativan) v. Oxazepam (Serax) vi. Chlordiazepoxide (Librium) vii. Clorazepate dipotassium (Tranxene) Prior Approval Renewal Limits Quantity 2 mg 540 tablets per 90 days

Appendix 1 - List of Serotonergic Medications Selective Serotonin Reuptake Inhibitors (SSRIs) paroxetine Paxil, Paxil CR, Pexeva, Brisdelle fluvoxamine Luvox, Luvox CR fluoxetine Prozac, Prozac Weekly, Sarafem, Selfemra, Symbyax sertraline Zoloft citalopram Celexa escitalopram Lexapro Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs) venlafaxine Effexor XR desvenlafaxine Pristiq, Khedezla duloxetine Cymbalta milnacipran Savella Tricyclic Antidepressants (TCAs) amitriptyline No brand name currently marketed desipramine Norpramin clomipramine Anafranil imipramine Tofranil, Tofranil PM nortriptyline Pamelor, Aventyl protriptyline Vivactil doxepin Zonalon, Silenor trimipramine Surmontil Monoamine Oxidase Inhibitors (MAOIs) isocarboxazid Marplan phenelzine Nardil selegiline Emsam, Eldepryl, Zelapar tranylcypromine Parnate Other Psychiatric Medicines amoxapine No brand name currently marketed maprotiline No brand name currently marketed nefazodone No brand name currently marketed trazodone Oleptro buspirone No brand name currently marketed vilazodone Viibryd mirtazapine Remeron, Remeron Soltab llthium Lithobid

Migraine Medicines almotriptan frovatriptan naratriptan rizatriptan sumatriptan zolmitriptan Axert Frova Amerge Maxalt, Maxalt-MLT Imitrex, Imitrex Statdose, Alsuma, Sumavel Dosepro, Zecuity, Treximet Zomig, Zomig-ZMT Antiemetics ondansetron granisetron dolasetron palonosetron Zofran, Zofran ODT, Zuplenz Kytril, Sancuso Anzemet Aloxi Other Serotonergic Medicines dextromethorphan linezolid cyclobenzaprine methylene blue St. John s wort tryptophan Bromfed-DM, Delsym, Mucinex DM, Nuedexta Zyvox Amrix